Unfortunately, semaglutide has not yet been thoroughly tested in people with depression
The article frames all of this as provider-run oversight rather than self-management, and pairs it with an expectation that patients report gastrointestinal distress, weight loss rate, or systemic symptoms so the prescriber can respond

S2 additional material).7,8 The incidence of PsO and HS has increased in western countries in recent decades.9,10 Obesity has increased in parallel, and could be responsible, at least partially, for the aforementioned increase.8 Psoriasis and obesity The prevalence of obesity is higher among patients with PsO than in the general population.1118 In addition, obesity increases the risk of PsO,6,19,20 the incidence of which could be twice as great in patients with grade II/III obesity compared with subjects with normal weight.21 Among the molecular mediators at the intersection between the 2 conditions are 3 adipokinesleptin, resistin, and adiponectinwhose levels impact the severity of PsO in patients with obesity.2224 Many complications associated with obesity are also associated with PsO
Chronic stress elevates cortisol and insulin resistance
RNA isolation and quantitative real-time PCR assay HBE cells were seeded in 6-well plates at a density of about 1 10 6 cells per well, and exposed to 50, 100, 250, or 500 g/ml Al 2 O 3 NPs or control medium for 24 h, then cells were trypsinized and collected
Table 1 summarizes the demographic and clinical characteristics of these patients during the acute phase and at the 12-month follow-up